Enrollment Completed In ONWARD’s LIFT Home Study
LIFT Home Study is designed to study the safety and performance of ARCEX Therapy when used in the home.
June 8, 2022
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
View the latest clinical trials, studies, data, and updates.
Bone Health Technologies to Conduct 1 Year Long Study with the San Francisco Veterans Affairs Health Care System
Bone Health Technologies is looking to enroll 50 patients with diverse racial and ethnic backgrounds who are not currently taking any osteoporosis drugs and have DXA scan bone density T-scores between -1.0 and -2.4.
June 8, 2022
Aerin Medical’s RhinAer Demonstrates Long-term Safety and Efficacy for Treatment of Chronic Rhinitis in Newly Published 2 Year Study
Data from the trial demonstrated that treatment with RhinAer to the posterior nasal nerve (PNN) is safe and provides significant, durable symptom improvement for both chronic non-allergic and allergic rhinitis patients.
June 7, 2022
Clinical Data Presented at American Diabetes Association 82nd Scientific Sessions Reinforce Significant and Durable Benefits of Nevro’s HFX 10 kHz Therapy
The data presented at the ADA 82nd Scientific Sessions highlighted 24-month results for the original 10 kHz arm of the SENZA-PDN trial, the largest PDN RCT of SCS treatment conducted to date with 216 randomized subjects at 18 U.S. centers.
June 7, 2022
Control-IQ Technology Continues to Demonstrate Positive and Sustained Real-World Benefits Across Diverse Cohorts of People with Diabetes
“Our Control-IQ technology continues to be a great equalizer for people with insulin-intensive diabetes, as we consistently see positive clinical and quality-of-life improvement with its use, regardless of age, ethnicity, or prior therapy,” said Jordan Pinsker, MD, Vice President and Medical Director for Tandem Diabetes Care.
June 6, 2022
Orbis Reports First-of-its-Kind Study Finds Artificial Intelligence Screenings Improve Eye Care Access in Sub-Saharan Africa
The study looked at whether the use of the Orbis Cybersight AI tool to detect diabetic retinopathy in images taken of the eye during routine screenings would lead to patients’ increased uptake of diabetic retinopathy referral services.
June 6, 2022
